Literature DB >> 30056427

Vascular Effects on Depressive Symptoms in Cognitive Impairment.

Yeshin Kim1,2,3, Hyemin Jang1,2, Seung Joo Kim1,2, Soo Hyun Cho1,2, Si Eun Kim1,2,4, Sung Tae Kim5, Hee Jin Kim1,2, Seung Hwan Moon2,6, Michael Ewers7, Kiho Im8, Hunki Kwon9, Duk L Na1,2,10,11, Sang Won Seo1,2,10,12.   

Abstract

Late life depression is related to pathologic burdens, such as cerebral small vascular disease (CSVD) and amyloid, which are associated with brain network changes and cortical thinning. To examine the associations of various CSVD imaging markers, amyloid, and network changes with depression in cognitively impaired patients, we prospectively recruited 228 cognitively impaired patients having various degrees of amyloid and CSVD who underwent diffuse tensor image and PiB PET. Greater CSVD burden was associated with greater Geriatric Depression Scale (GDS) (white matter hyperintensities, WMH: p = 0.025, lacunes: p < 0.001) but not with amyloid (p = 0.095), and cortical thinning (p = 0.630) was not associated with greater GDS. The changes in white matter networks were related to GDS with decreasing integration (global efficiency: p < 0.001) and increasing segregation (clustering coefficient: p = 0.009). The network changes mediated the relationships of WMH and lacunes with GDS. Our findings provide insight to better understand how CSVD burdens contribute to depression in cognitively impaired patients having varying degrees of amyloid and vascular burdens.

Entities:  

Keywords:  Depression; network; small vessel disease

Mesh:

Substances:

Year:  2018        PMID: 30056427     DOI: 10.3233/JAD-180394

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  2 in total

Review 1.  The enigma of vascular depression in old age: a critical update.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2022-06-15       Impact factor: 3.850

Review 2.  Pathomechanisms of Vascular Depression in Older Adults.

Authors:  Kurt A Jellinger
Journal:  Int J Mol Sci       Date:  2021-12-28       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.